The family of the late Raymond Sackler, left, who own OxyContin manufacturer Purdue Pharma, have denied allegations on new website. Raymond s son Richard, right, was CEO.
Oxford University s Sackler Library is named after multi-millionaire donor Dr Mortimer Sackler, who co-owned Purdue Pharma. The company that created the drug OxyContin.
Members of billionaire Sackler family who own OxyContin maker Purdue Pharma whined in emails about falling behind financially after being blamed for fueling the opioid crisis
Members of the billionaire Sackler family, who own OxyContin maker Purdue Pharma, reportedly complained in emails about falling behind financially
Email in question dates back to 2017 when Mortimer, the son of Mortimer Sackler Sr, requested a $10million loan from the family trust
The younger Mortimer wrote to a confidant: Start off with saying I am not happy. I am falling significantly behind financially
Emails were revealed in Patrick Radden Keefe s new book Empire of Pain
Billionaire Sackler family to relinquish control of OxyContin maker Purdue Pharma in bankruptcy plan and agrees to pay nearly $4.3 BILLION to resolve thousands of opioid lawsuits
Members of the Sackler family, who own Purdue Pharma, have agreed to pay $4.3 billion to resolve lawsuits accusing them of fueling the opioid crisis
The huge payment from the Sacklers is part of a larger restructuring plan filed by Purdue on Monday to get the pharmaceutical giant out of bankruptcy
Purdue s plan calls for it to be transformed into an entity that would see the Sacklers relinquish control and steer revenue directly to plaintiffs
Global consulting giant McKinsey & Company agrees to pay $573million settlement for role in opioid crisis after advising drug companies on how to supercharge sales
McKinsey & Co. agreed to $573million settlement with 47 states, DC, and 5 US territories over its role in advising OxyContin maker Purdue Pharma
Criticism of McKinsey escalated since New York Times report from November claimed the firm advised Purdue Pharma on ways to supercharge drug sales
In December, McKinsey apologized for its work with Purdue Pharma and vowed to probe claims two senior partners discussed deleting records linked to firm
McKinsey reportedly proposed that Purdue Pharma pay distributors rebates for overdoses linked to the pills sold by the company